Speaker illustration

Doctor Anca Remes

Christian-Albrechts-University Kiel, Kiel (Germany)

Member of:

European Society of Cardiology

Regnase-1 overexpression as a novel gene therapy approach for pulmonary hypertension

Event: ESC Congress 2022

Topic: Hypertension, Pulmonary Hypertension

Session: New insights and therapeutic options in pulmonary arterial hypertension

Thumbnail

L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel target for heart failure due to pressure overload

Event: ESC Congress 2019

Topic: Heart Failure

Session: Cardiac hypertrophy

Thumbnail

L-2-hydroxyglutarate dehydrogenase (L2HGDH) is a novel metabolic target protecting from cardiac hypertrophy and heart failure

Event: Heart Failure 2019

Topic: Cardiac Hypertrophy

Session: Rapid Fire 1 - Basic Science

Thumbnail

AAV9-mediated delivery of a NFAT decoy oligonucleotide prevents pathological myocardial hypertrophy and heart failure in mice

Event: ESC Congress 2018

Topic: Experimental Heart Failure

Session: Chronic heart failure – pathophysiology and mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb